Objectif The innovation consists in the proprietary method and mechanism for maintaining the smart material- Electroactive Polymers(EAP) - in a pre-stretch state. This revolutionary technology manipulates the EAP film into thin, linear actuators, forintegration in numerous healthcare devices. Highly suitable for wearable devices, the EAPs expand and contract whenstimulated by an electric field.ComFyt - the first application of our innovation - is a smart stocking designed for venous disease patients. ComFyt can beworn throughout the day everywhere. It massages the leg mimicking calf muscle contractions and treating potentially lifethreatening circulatory conditions. Its agility and flexibility solves the problem of low compliance and comfort of the currentcompression therapy devices.Blood circulation is a crucial part of the human anatomy, ensuring nutrient and oxygen delivery to all the cells in the body.Poor circulation can cause painful VDs, such as edema, varicose veins, lymphedema, and multiple sports injuries, whichgreatly affect the patient’s quality of life. Life threatening disorders, such as Chronic Venous Insufficiency and Deep VeinThrombosis (DVT) are serious conditions caused by compromised circulation too. Every year, approximately 10 millionpeople suffer from DVT worldwide. Champ scientifique natural sciencescomputer and information sciencesinternetinternet of thingsmedical and health sciencesbasic medicineanatomy and morphologymedical and health sciencesclinical medicineangiologyvascular diseasessocial sciencespolitical sciencespolitical transitionsrevolutionsnatural scienceschemical sciencespolymer sciences Programme(s) H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs Main Programme H2020-EU.3. - PRIORITY 'Societal challenges H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies Thème(s) EIC-SMEInst-2018-2020 - SME instrument Appel à propositions H2020-EIC-SMEInst-2018-2020 Voir d’autres projets de cet appel Sous appel H2020-SMEInst-2018-2020-2 Régime de financement SME-2 - SME instrument phase 2 Coordinateur ELASTIMED LTD Contribution nette de l'UE € 1 336 142,50 Adresse HATCHELET 17 2017900 MISGAV IP Israël Voir sur la carte PME L’entreprise s’est définie comme une PME (petite et moyenne entreprise) au moment de la signature de la convention de subvention. Oui Type d’activité Private for-profit entities (excluding Higher or Secondary Education Establishments) Liens Contacter l’organisation Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Coût total € 1 908 775,00
